Parmax Pharma Ltd - 540359 - Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pravina Mahasukhlal Gopani Parmax Pharma Ltd - 540359 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
In pursuance to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to kindly intimate you that the Company has received information through its Registrar and Share Transfer Agents i.e. Purva Sharegistry India Private Limited that the following share certificate has been reported as lost or misplaced: Parmax Pharma Ltd - 540359 - Unaudited Financial Results For Quarter And Half Year Ended 30Th September, 2020
This is to inform you that the Board of Directors of the Company has, at its meeting held today, i.e. 12th November, 2020, inter-alia, considered and approved the Unaudited Financial Results for quarter and half year ended 30th September, 2020. The same has also been reviewed by the Audit Committee in its meeting held today. A copy of the Statement of Unaudited Financial Results for the quarter and half year ended 30th September, 2020, approved by the Board pursuant to Regulation 33 of the Securities And Exchange Board of India (LODR Regulations, 2015, is enclosed for your reference and record. The meeting commenced at 2:00 pm and concluded 6:40 pm Parmax Pharma Ltd - 540359 - Outcome Of The Board Meeting Held On 12Th November, 2020
This is to inform you that the Board of Directors of the Company has, at its meeting held today, i.e. 12th November, 2020, inter-alia, considered and approved the Unaudited Financial Results for quarter and half year ended 30th September, 2020. The same has also been reviewed by the Audit Committee in its meeting held today. A copy of the Statement of Unaudited Financial Results for the quarter and half year ended 30th September, 2020, approved by the Board pursuant to Regulation 33 of the Securities And Exchange Board of India (LODR Regulations, 2015, is enclosed for your reference and record. The meeting commenced at 2:00 pm and concluded 6:40 pm. We would like to submit that M/ s. B A Shah S R Mehta & Co., Statutory Auditors of Company have carried out limited review of Unaudited Financial Results for quarter ended and half year ended 30th September, 2020 and Board has also taken on record their Limited Review Report on said Results. Parmax Pharma Ltd - 540359 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding loss of share certificate under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Parmax Pharma Ltd - 540359 - Board Meeting Intimation for Intimation Of Board Meeting In Compliance With Reg. 29 Read With Reg. 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Parmax Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2020 ,inter alia, to consider and approve Pursuant to Regulation 29(1) and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to notify that a meeting of the Board of Directors of the Company is proposed to be held on Thursday, the 12th November, 2020 at 2:00 P.M. to, inter-alia, consider, approve and take on the record the Un-audited Financial Results for the quarter and half year ended 30th September, 2020. Parmax Pharma Ltd - 540359 - Certificate Pursuant To Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended 30Th September, 2020
Pursuant to the provisions of Regulation 40(10) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we are enclosing herewith the certificate received from Mr. Samsad Alam Khan, Practicing Company Secretaries, for the half-year ended 30th September, 2020 confirming the compliance of Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This is for your kind information and record please. Parmax Pharma Ltd - 540359 - Shareholding for the Period Ended September 30, 2020
Parmax Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click here Parmax Pharma Ltd - 540359 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Parmax Pharma Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Parmax Pharma Ltd - 540359 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Pursuant to Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''SEBI Listing Regulations)'', we hereby enclose the voting results of 26th Annual General Meeting held on Friday, the 16th October, 2020 at 02:00 p.m. (IST) and Consolidated Scrutinizer''s Report pursuant to Section 108 of the Companies Act 2013 and Rule 20(4)(xii) of the Companies (Management and Administration) Rules, 2014 Based on combined results, we report that, all the resolutions as per the Notice of the 26th AGM of the Company stands passed with requisite majority.